Immunosuppressant rapamycin inhibits protein kinase C α and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis

Chun Do Oh, Song Ja Kim, Jung Won Ju, Woo Keun Song, Jae Hong Kim, Yung Joon Yoo, Jang Soo Chun

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)


Immunosuppressants are now known to modulate bone metabolism, including bone formation and resorption. Because cartilage, formed by differentiated chondrocytes, serves as a template for endochondral bone formation, we examined the effects of the immunosuppressant rapamycin on the chondrogenesis of mesenchymal cells and on the cell signaling that is required for chondrogenesis, such as protein kinase C, extracellular signal-regulated kinase-1 (ERK-1), and p38 mitogen-activated protein (MAP) kinase pathways. Rapamycin inhibited the expression of type II collagen and the accumulation of sulfate glycosaminoglycan, indicating inhibition of the chondrogenesis of mesenchymal cells. Rapamycin treatment did not affect precartilage condensation, but it prevented cartilage nodule formation. Exposure of chondrifying mesenchymal cells to rapamycin blocked activation of the protein kinase C α and p38 MAP kinase, but had no discernible effect on ERK-1 signaling. Selective inhibition of PKCα or p38 MAP kinase activity, which is dramatically increased during chondrogenesis, with specific inhibitors in the absence of rapamycin blocked the chondrogenic differentiation of mesenchymal cells. Taken together, our data indicate that the immunosuppressant rapamycin inhibits the chondrogenesis of mesenchymal cells at the post-precartilage condensation stage by modulating signaling pathways including those of PKCα and p38 MAP kinase.

Original languageEnglish
Pages (from-to)175-185
Number of pages11
JournalEuropean Journal of Pharmacology
Issue number3
Publication statusPublished - 2001 Sept 21
Externally publishedYes

Bibliographical note

Funding Information:
This study was supported by a grant of the Korea Health 21 R&D Project (HMP-00-B-20700-0018), Ministry of Health and Welfare. S.J. Kim and C.D. Oh were supported by Brain Korea 21 Research program and W.K. Song was supported in part by a grant from the Korea Ministry of Science and Technology (Life Phenomena and Function Research Group).


  • Chondrogenesis
  • Mesenchymal cells
  • Micromass culture
  • Protein kinase C α
  • Rapamycin
  • p38 MAP (mitogen-activated protein) kinase

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Immunosuppressant rapamycin inhibits protein kinase C α and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis'. Together they form a unique fingerprint.

Cite this